sub field
BiotechLongevity
About
Salah Mahmoudi is a biotech entrepreneur with a PhD, best known as CEO & Co-founder of ReneuBio Inc., a Berkeley SkyDeck-backed startup developing medicines for age-related neurological conditions. He previously held an Associate Director role at Alkahest (a plasma-based aging therapeutics company) and co-founded Norachem, a chemistry startup. He is active in the longevity conference circuit and investor ecosystem, connected to prominent longevity investors including Karl R. Pfleger, though his primary identity is operator-founder rather than fund-deploying investor.
Areas of interest
longevityaging biologyneurodegenerationdrug discoveryAI in drug developmentbiotechrejuvenation biotechnologyplasma therapiesmedicinal chemistrydevelopability risk